|
|
|
Volumn 32, Issue 4, 1996, Pages 731-740
|
|
Glycinergic augmentation of NMDA receptor-mediated neurotransmission in the treatment of schizophrenia
a |
|
Author keywords
glycine; N methyl D aspartate (NMDA); negative symptoms; phencyclidine; Positive and Negative Syndrome Scale (PANSS); schizophrenia
|
|
Indexed keywords
CHLORPROMAZINE;
GLUTAMATE RECEPTOR;
GLUTAMIC ACID;
GLYCINE;
GLYCINE RECEPTOR;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR;
NEUROLEPTIC AGENT;
PHENCYCLIDINE;
PLACEBO;
CLINICAL TRIAL;
CONFERENCE PAPER;
DIET SUPPLEMENTATION;
DRUG EFFICACY;
DRUG POTENTIATION;
HUMAN;
NEGATIVE SYNDROME;
NEUROTRANSMISSION;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
SCHIZOPHRENIA;
ADULT;
DOUBLE-BLIND METHOD;
FEMALE;
GLYCINE;
HUMANS;
MALE;
RECEPTORS, N-METHYL-D-ASPARTATE;
SCHIZOPHRENIA;
SYNAPTIC TRANSMISSION;
|
|
EID: 0030480590
PISSN: 00485764
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (50)
|
|
References (1)
|
